info icon

This is a non-core endpoint: only basic statistics are computed.

Refsum disease

G6_REFSUM

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 G60.1
  • Hospital discharge: ICD-9 3563
  • Cause of death: ICD-10 G60.1
  • Cause of death: ICD-9 3563

2 out of 7 registries used, show all original rules.

13

4. Check minimum number of events

None

13

5. Include endpoints

None

13

6. Filter based on genotype QC (FinnGen only)

13

Control definitions (FinnGen only)

Control exclude
G6_POLYNEU

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G60
Name in latin
Morbus Refsum

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 104 49 55
Only index persons 88 45 43
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 54.65 58.71
Only index persons 55.90 54.65 57.20

-FinnGen-

Key figures

All Female Male
Number of individuals 13 - 11
Unadjusted period prevalence (%) 0.00 - 0.00
Median age at first event (years) 63.48 - 63.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011397) Hemoglobin [Presence] in Urine by Test strip
5
22
3.04
1.15
4.8
5.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
26
2.48
0.81
2.8
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
5
27
2.37
0.78
3.4
2.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
5
29
2.16
0.72
7.6
5.3
—
—
—
0
0
(3015736) pH of Urine
6
39
1.99
0.46
5.8
5.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
6
40
1.92
0.46
8.7
11.1
e9/l
0.0
0.0
—
6
35
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
6
42
1.79
0.44
4.3
4.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
0
14
0.00
0.44
0.0
4.9
—
32.1
—
0
9
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6
43
1.73
0.43
4.0
3.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
8
66
1.55
0.25
4.1
5.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
6
72
0.69
0.24
6.0
5.2
ug/l
1.7
2.7
—
6
62
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
0
11
0.00
0.22
0.0
1.2
—
1.4
—
0
6
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
0
10
0.00
0.22
0.0
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
0
10
0.00
0.22
0.0
3.8
—
6.6
—
0
10
(4035726)
0
12
0.00
0.22
0.0
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.22
0.0
4.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
5
41
1.35
0.12
6.8
5.3
—
—
—
0
0
(3044889) 12 lead EKG panel
8
72
1.29
0.11
4.3
4.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
8
72
1.29
0.11
29.0
24.2
g/l
334.3
334.1
—
8
72
(3018405) Lactate [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
2.2
—
0
6
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
2.3
—
4.1
—
0
6
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
0
6
0.00
0.00
0.0
1.5
—
92.7
—
0
6
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
9
0.00
0.00
0.0
5.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4010399)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3000492) Spirometry study
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(4268621)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
6
63
0.91
0.00
4.0
5.2
mmol/l
7.3
7.1
—
6
57
(3036489) Thrombin time
0
7
0.00
0.00
0.0
1.7
—
19.7
—
0
7
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint G6_REFSUM and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have G6_REFSUM.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: G6_REFSUM – Refsum disease

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data